Yáñez Y - Search Results

1

Neuroblastoma in adolescents: genetic and clinical characterisation.

Castel V, Villamón E, Cañete A, Navarro S, Ruiz A, Melero C, Herrero A, Yáñez Y, Noguera R. Castel V, et al. Among authors: yanez y. Clin Transl Oncol. 2010 Jan;12(1):49-54. doi: 10.1007/s12094-010-0466-z. Clin Transl Oncol. 2010. PMID: 20080471

2

Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients.

Grau E, Martinez F, Orellana C, Canete A, Yañez Y, Oltra S, Noguera R, Hernandez M, Bermúdez JD, Castel V. Grau E, et al. Among authors: yanez y. J Cancer Res Clin Oncol. 2010 Sep;136(9):1415-21. doi: 10.1007/s00432-010-0796-9. Epub 2010 Feb 7. J Cancer Res Clin Oncol. 2010. PMID: 20140741

3

Distribution of segmental chromosomal alterations in neuroblastoma.

Juan Ribelles A, Gargallo P, Ferriol C, Segura V, Yáñez Y, Juan B, Cañada AJ, Font de Mora J, Cañete A, Castel V. Juan Ribelles A, et al. Among authors: yanez y. Clin Transl Oncol. 2021 Jun;23(6):1096-1104. doi: 10.1007/s12094-020-02497-2. Epub 2020 Sep 18. Clin Transl Oncol. 2021. PMID: 32948984

4

Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.

Yáñez Y, Grau E, Oltra S, Cañete A, Martínez F, Orellana C, Noguera R, Palanca S, Castel V. Yáñez Y, et al. J Cancer Res Clin Oncol. 2011 Aug;137(8):1263-72. doi: 10.1007/s00432-011-0997-x. Epub 2011 Jun 25. J Cancer Res Clin Oncol. 2011. PMID: 21706131

5

TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients.

Yáñez Y, Hervás D, Grau E, Oltra S, Pérez G, Palanca S, Bermúdez M, Márquez C, Cañete A, Castel V. Yáñez Y, et al. J Cancer Res Clin Oncol. 2016 Mar;142(3):573-80. doi: 10.1007/s00432-015-2054-7. Epub 2015 Oct 24. J Cancer Res Clin Oncol. 2016. PMID: 26498952

6

Letter to the Editor.

Castel V, Cañete A, Calabria I, Cervera J, Dolz S, Escobar P, Font de Mora J, Gargallo P, Llavador G, Pedrola L, Yañez Y, Zuñiga A. Castel V, et al. Among authors: yanez y. Clin Transl Oncol. 2018 Dec;20(12):1626-1627. doi: 10.1007/s12094-018-1889-1. Epub 2018 May 28. Clin Transl Oncol. 2018. PMID: 29808413 No abstract available.

7

Li-Fraumeni syndrome heterogeneity.

Gargallo P, Yáñez Y, Segura V, Juan A, Torres B, Balaguer J, Oltra S, Castel V, Cañete A. Gargallo P, et al. Among authors: yanez y. Clin Transl Oncol. 2020 Jul;22(7):978-988. doi: 10.1007/s12094-019-02236-2. Epub 2019 Nov 5. Clin Transl Oncol. 2020. PMID: 31691207 Review.

8

Precision medicine in Ewing sarcoma: a translational point of view.

Gargallo P, Juan A, Yáñez Y, Dolz S, Segura V, Castel V, Cañete A. Gargallo P, et al. Among authors: yanez y. Clin Transl Oncol. 2020 Sep;22(9):1440-1454. doi: 10.1007/s12094-020-02298-7. Epub 2020 Feb 5. Clin Transl Oncol. 2020. PMID: 32026343 Review.

9

Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease.

Grau E, Martinez F, Orellana C, Canete A, Yañez Y, Oltra S, Noguera R, Hernandez M, Bermúdez JD, Castel V. Grau E, et al. Among authors: yanez y. Mol Carcinog. 2011 Mar;50(3):153-62. doi: 10.1002/mc.20700. Epub 2010 Nov 23. Mol Carcinog. 2011. PMID: 21104989

10

New prognostic markers in neuroblastoma.

Navarro S, Piqueras M, Villamón E, Yáñez Y, Balaguer J, Cañete A, Noguera R. Navarro S, et al. Among authors: yanez y. Expert Opin Med Diagn. 2012 Nov;6(6):555-67. doi: 10.1517/17530059.2012.704018. Epub 2012 Jul 11. Expert Opin Med Diagn. 2012. PMID: 23480837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page